Dyax Corp.
(NASDAQ : DYAX)

( )
DYAX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.01%162.850.7%$1390.69m
PFEPfizer Inc. -0.03%33.790.9%$1240.93m
BMYBristol-Myers Squibb Co. -0.26%61.891.0%$873.62m
MRKMerck & Co., Inc. 0.05%74.620.7%$835.84m
ABBVAbbVie, Inc. -0.07%107.331.9%$808.53m
LLYEli Lilly & Co. 0.25%204.211.1%$783.66m
AZNAstraZeneca Plc 0.18%49.001.2%$521.07m
GSKGlaxoSmithKline Plc -0.67%34.150.2%$268.59m
NVSNovartis AG 0.73%87.400.2%$192.24m
SNYSanofi 1.27%46.380.2%$170.56m
VTRSViatris, Inc. -0.86%14.920.0%$143.06m
VERUVeru, Inc. -3.36%13.800.0%$114.97m
CVACCureVac NV 3.26%96.000.0%$109.72m
VYNEVYNE Therapeutics, Inc. -4.94%7.500.0%$95.25m
NVONovo Nordisk A/S 0.00%72.340.1%$93.02m

Company Profile

Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA.